Serial 98976969
Live / Registered — Registered (as of 25 Nov 2025)
What this means for you
Registered since 25 Nov 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Nov 2031: the §8 declaration of use).
Record
- Serial number
- 98976969
- Registration number
- 8044794
- Mark type
- Design / logo
- Filed
- 14 Feb 2024
- Published for opposition
- 11 Mar 2025
- Registered
- 25 Nov 2025
- Next maintenance filing
- §8 declaration of use, due by 25 Nov 2031 (grace period to 25 May 2032)
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia
- Class 044 — Medical, beauty and agricultural services: Providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 19 Aug 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 17 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Aug 2025 — USE AMENDMENT FILED
- 05 Nov 2025 — DIVISIONAL PROCESSING COMPLETE
- 21 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 04 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 21 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED